Page 5 - Diet And Dementia Casein Antioxidants DHEA

References

Beckman KB and Ames BN. 1998. The Free Radical Theory of Aging Matures. Physiological Reviews
78(2):547-581.

Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR, Markesbery WR, and Mattson MP.
1998. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic Neurons and impairs
visuospatial memory in rats. Journal of Neuropathology and Experimental Neurology 57:257-267

Cantui-Castelverti I, Shukitt-Hale B, and Joseph JA. 2000. Neurobehavioral aspects of antioxidants in
aging. Int. J. Devl Neuroscience 18:367-381.

Dodd CE, Zicker SC, Lowry SR, et al. Effects of an investigational food on age-related behavioral
changes in dogs. Proceedings. Symposium on Brain Aging and Related Behavioral Changes in
Dogs. Orlando, Florida, 2002.

Dodd CE, Zicker SC, Jewell DE, et al. Can a fortified food affect the behavioral manifestations of
age-related cognitive decline in dogs? Vet Med 2003; 98: 396-408.

Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, and Ames BN. 1999.
R-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative
damage, and increased metabolic rate. FASEB Journal 13:411-418.

Keller JN, Hanni KB and Markesbery WR. 1999. 4-Hydroxynonenal increases neuronal susceptibility to
oxidative stress. Journal of Neuroscience Research 58:823-830.

Lykkesfeldt J, Hagen TM, Vinarsky V, and Ames BN. 1998. Age-associated decline in ascorbic acid
concentration, recycling, and biosynthesis in rat hepatocytes- reversal with R-alpha-lipoic acid
supplementation. FASEB Journal 12:1183-1189.

Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, and Inestrosa NC. 2000. The role of
oxidative stress in the toxicity induced by amyloid Beta-peptide in Alzheimers disease. Progress in
Neurobiology 62:633-648.

Pratico D, Lee VM, Trojanowski Q, Rokach J, and Fitzgerald GA. 1998. Increased F2-isoprostanes in
Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivo. FASEB Journal 12, 1777-1783.

Sano M, Ernesto C, Ghomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman
CW, Pfeiffer E, Schneider LS and Thal L. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as
treatment for alzheimer’s disease. New England Journal of Medicine 336:1216-1222.